Adaptable, At-Home Covid Testing Device Developed At KU Receives Funding Boost
An at-home COVID-19 testing device developed by a University of Kansas professor is another step closer to hitting the market.
BioFluidica, a company co-founded by Steven Soper, announced in early February it has received $6 million in Series B2 financing to help bring its LiquidScan instrument to production. Soper — who is a Foundation Distinguished Professor with appointments in the School of Engineering and Department of Chemistry — has spent much of the last two years repurposing “lab on a chip” technology he had previously developed to give doctors simple tools to more easily and quickly diagnose conditions ranging from stroke to different cancers.